Key result
Intracoronary infusion of L-NAME did not alter pacing-induced increases in coronary blood flow, myocardial oxygen consumption, or regional myocardial blood flow in anesthetized dogs.
Why the study?
Does inhibition of EDNO synthesis with L-NAME alter metabolic coronary vasodilation induced by pacing tachycardia in anesthetized dogs?
Does inhibition of EDNO synthesis with L-NAME alter metabolic coronary vasodilation induced by pacing tachycardia in anesthetized dogs?
Endothelium-derived nitric oxide does not play a primary role in mediating metabolic coronary vasodilation induced by pacing tachycardia in dogs.
Answers are grounded in this paper and cite their sources.
EDNO inhibition does not affect metabolic coronary vasodilation in dogs; leaves open its role in other species or human physiology.
Endothelium-derived nitric oxide (EDNO) has been implicated in the modulation of coronary arterial tone. The aim of this study was to determine if metabolic coronary vasodilation induced by pacing tachycardia is altered by the inhibition of EDNO synthesis. Before and after the intracoronary infusion of an inhibitor of EDNO synthesis (N omega-nitro-L-arginine-methyl-ester, L-NAME), changes in coronary blood flow (CBF), regional myocardial blood flow (MBF), and myocardial oxygen consumption (MVO2) were measured in anesthetized dogs in response to atrial pacing tachycardia. Increasing the heart rate from 109 +/- 10 to 160 beats/min by pacing produced significant increases in CBF (p < 0.05), MVO2 (p < 0.05), and MBF in each sublayer of the myocardium (p < 0.05). L-NAME did not alter the pacing-induced increases in CBF, MVO2, or regional MBF. In addition, the ratio of the tachycardia-induced increase in CBF to the increase in MVO2 was not changed by L-NAME. The coronary vasodilation evoked by acetylcholine was attenuated by L-NAME (p < 0.05). However, the response to sodium nitroprusside was not altered. These results suggest that EDNO does not play a primary role in the mechanism mediating metabolic coronary vasodilation induced by pacing tachycardia in dogs.
No takes yet. Share an insight, caveat, or question.
Katsuda et al. (1995) studied this question. L-NAME (N omega-nitro-L-arginine-methyl-ester) vs. Before L-NAME infusion was evaluated on Changes in coronary blood flow (CBF), regional myocardial blood flow (MBF), and myocardial oxygen consumption (MVO2). Intracoronary infusion of L-NAME did not alter pacing-induced increases in coronary blood flow, myocardial oxygen consumption, or regional myocardial blood flow in anesthetized dogs.
Synapse has enriched 10 related papers. Consider them for comparative context: